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Highlights: 
· The circadian clock controls rhythmic mitochondrial dynamics and metabolic flux. 
· DRP1 is phosphorylated in circadian fashion. 
· Suppression of DRP1 activity eliminates circadian ATP production. 
· Blocking DRP1 function impairs the core circadian clock. 
 
eTOC Blurb/ In Brief: 
Schmitt et al. demonstrate that the circadian clock globally regulates mitochondrial morphology 
and energy metabolism. Even in non-dividing tissues, rhythmic control of DRP1 phosphorylation 
directs circadian mitochondrial morphology. This control is not only essential for circadian ATP 
production, but also feeds back to influence the core circadian clock. 
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Summary 
Mitochondrial fission-fusion dynamics and mitochondrial bioenergetics, including 
oxidative phosphorylation and generation of ATP, are strongly clock-controlled. Here we show 
that these circadian oscillations depend on circadian modification of Dynamin-related Protein 1 
(DRP1), a key mediator of mitochondrial fission. We used a combination of in vitro and in vivo 
models, including human skin fibroblasts and DRP1-deficient or clock-deficient mice, to show 
that these dynamics are clock-controlled via circadian regulation of DRP1. Genetic or 
pharmacological abrogation of DRP1 activity abolished circadian network dynamics and 
mitochondrial respiratory activity, and eliminated circadian ATP production. Pharmacological 
silencing of pathways regulating circadian metabolism and mitochondrial function (e.g. sirtuins, 
AMPK) also altered DRP1 phosphorylation, and abrogation of DRP1 activity impaired circadian 
function. Our findings provide new insight into the crosstalk between the mitochondrial network 
and circadian cycles. 
Keywords 
Bioenergetics; circadian clock; DRP1; dynamics; fission, fusion, glycolysis, metabolism, 
mitochondria, oxidative phosphorylation. 
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Introduction 
The circadian clock is a hierarchical network of oscillators that synchronize a wide 
variety of metabolic pathways to the optimal time of day, anticipating periodic changes of the 
external environment for all living organisms, from cyanobacteria and fungi (Brunner and 
Schafmeier, 2006) to insects (Rosato et al., 2006) and mammals (Gachon et al., 2004). 
Over the years, a growing body of evidence has emerged specifically suggesting that 
energy metabolism and cellular antioxidant mechanisms defending against oxidative damages 
are coordinated by the circadian clock. Conversely, disruption of the clock impairs metabolic 
homeostasis (McGinnis and Young, 2016). The circadian clock exerts its control over 
metabolism by (i) controlling the expression of genes and enzymes involved in metabolic 
processes (Eckel-Mahan et al., 2012, Feng et al., 2011, Vollmers et al., 2009), (ii) intertwining 
nuclear receptors and nutrient sensors with the clock machinery, e.g. PER2/CLOCK and SIRT1 
(Asher et al., 2008, Nakahata et al., 2008); PER2 and PPARα/REV-ERBα (Schmutz et al., 2010), 
CRY1 and AMPK/GCR (Lamia et al., 2011, Lamia et al., 2009); and REV-ERBa and HDAC3 
(Zhang et al., 2015), and/ or (iii) regulating metabolite levels (e.g. NAD
+
/NADH; ATP/ADP; 
cAMP) (Nakahata et al., 2009, O'Neill et al., 2008, Peek et al., 2013, Ramsey et al., 2009). 
Conversely, various hormones, nutrient and redox sensors as well as metabolites not only act as 
clock output but can, in turn, also regulate the biological clock by acting as input signals (Bass, 
2012, Eckel-Mahan and Sassone-Corsi, 2013). 
Within this network, the mechanistic relationship between the clock and the 
mitochondrial network remains mostly elusive. Mitochondria are highly dynamic cellular 
organelles playing a major role in cellular energy metabolism and homeostasis via generation of 
several metabolites including adenosine triphosphate (ATP). Several studies have shown diurnal 
oscillations not only in mitochondrial gene expression (Panda et al., 2002), but also in key 
mitochondrial bioenergetic parameters including membrane potential, cytochrome c oxidase 
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activity and key mitochondrial enzymes (Isobe et al., 2011, Neufeld-Cohen et al., 2016). 
Moreover, one regulatory node for mitochondrial oxidative metabolism is the level of 
NAD
+
/NADH, which regulates the activity of mitochondrial sirtuins and thereby mitochondrial 
protein acetylation (Nakahata et al., 2009, Peek et al., 2013, Masri et al., 2013). However, in 
other systems such as the cell cycle, global control of mitochondrial function is strongly 
coordinated with morphology (Lopez-Mejia and Fajas, 2015, Wai and Langer, 2016). For 
example, in response to cues from the cell cycle, a tightly regulated equilibrium between 
opposing mitochondrial fusion and fission activities is required to meet changing demands for 
energy production and to adjust mitochondrial function (Kanfer and Kornmann, 2016). In this 
paper, we show that similar mechanisms are used by the circadian clock to regulate the 
mitochondrial network: even in non-dividing cells and tissues, circadian regulation of dynamin-
related protein 1 (DRP1) results in cycles of fission and fusion that are essential for circadian 
oscillations in ATP production. Our findings are consistent with the existence of a crosstalk 
between the clock and the mitochondrial network that maintains bioenergetic homeostasis in 
response to circadian metabolic changes. 
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Results & Discussion 
Cellular bioenergetic variations are driven by the circadian clock. 
To eliminate potential systemic and environmental influences upon metabolic 
measurements and to establish an in vitro system for mechanistic study, global metabolomic 
profiles were first obtained from cultured human osteosarcoma U2OS cells over the course of 24 
hours after synchronizing circadian clocks with dexamethasone (Fig 1A-C, Fig S1A-E, Table 
1). Similar to circadian pathway signatures of the cellular metabolome previously described in 
rodents (Eckel-Mahan et al., 2012, Minami et al., 2009, Adamovich et al., 2014, Vollmers et al., 
2009) and humans (Ang et al., 2012, Dallmann et al., 2012, Davies et al., 2014, Kasukawa et al., 
2012), periodic analysis (Hughes et al., 2010) showed that ~29% of these metabolites (67 of 228 
identified metabolites) displayed circadian rhythmicity, mainly peaking at 16 hours after 
synchronization (Fig 1A-C, Fig S1A-E, Table 1). A range of these rhythmic compounds were 
engaged in redox and mitochondrial energetic homeostasis through branched-chain amino acid 
metabolism, the GSH/GSSG redox system, glycolysis, the tricarboxylic acid (TCA) cycle (Fig 
S1 B-E), or metabolic byproducts of mitochondrial metabolism (i.e. ATP, reactive oxygen 
species and NAD
+
/NADH) (Fig. S1F-I), as has been observed by others in heterologous 
mammalian systems (Eckel-Mahan et al., 2012, Peek et al., 2013). The group of mitochondrial 
fuels showed peak expression levels about six hours earlier than the “byproduct” group. In 
fibroblasts from mPer1/Per2 mutant mice, which lack a functional circadian clock (Zheng et al., 
2001),ATP levels remain constant at nadir levels (Fig 1D). Thus, rhythmic ATP levels depend 
upon a functional circadian clock.  
Since the circadian clock can be phase-locked with the cell cycle (Matsuo et al., 2003), 
and ATP levels are cell cycle-regulated (Marcussen and Larsen, 1996), we also verified ATP 
content in synchronized fibroblasts treated with cytosine β-D-arabinofuranoside (AraC) to 
abrogate cell division (Fig. S2A-C). Although disruption of cell division with AraC led to a 
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moderately decreased rhythmic ATP content (Fig. S2B), no alteration in the amplitude of 
circadian ATP production was observed (Fig. S2A, C). Circadian ATP levels as well as 
circadian NAD
+
 and NADH levels were also observed in adult wild-type mouse brains, where 
dividing cells represent a small minority (Fig. S2D-F). 
Finally, to confirm that this rhythmicity was dependent upon mitochondrial oxidative 
phosphorylation (OxPhos) rather than glycolysis, we also monitored ATP content in 
synchronized fibroblasts in the presence of oligomycin, an ATP synthase inhibitor, or 2-deoxy-
glucose, a glycolysis inhibitor, to determine the relative contribution of each pathway to the 
observed ATP oscillations (Fig. 1E). Whereas circadian ATP oscillations were significantly 
dampened by oligomycin treatment, 2-deoxy-glucose only decreased ATP levels while 
rhythmicity was maintained, confirming that circadian ATP rhythmicity is primarily caused by 
mitochondrial OxPhos. Collectively, these data not only confirm that mitochondrial output is 
circadian and cell cycle-independent, but that circadian control likely affects multiple steps of 
mitochondrial oxidative phosphorylation. We therefore began to dissect the sources of this 
control. 
Circadian mitochondrial bioenergetics are coupled to circadian mitochondrial 
architecture. 
Previous studies have suggested circadian bioenergetics in both SCN and liver (Isobe et 
al., 2011, Peek et al., 2013). Similarly, in cultured fibroblasts mitochondrial oxygen consumption 
analyses showed time-of-day-dependent variation in each measurable step of the mitochondrial 
respiratory chain: at 16 hours post-synchronization in cultured cells (and during the mouse 
subjective day), cells exhibited a higher respiratory capacity corresponding to high ATP levels; 
and at 28 hours post-synchronization (during the subjective night), cells showed lower spare 
respiratory capacity corresponding to low ATP levels (Fig 1F, G). By contrast, oxygen 
consumption allocated to other sources such as proton leak, or glycolysis (as reflected by the 
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extracellular acidification rate, or ECAR) remained unchanged at different time points (Fig. 
S2G, H). Thus, in cultured cells only mitochondrial respiration, but not glycolysis, varied in a 
circadian manner by switching between metabolically active and resting states, corresponding to 
16 and 28 hours post-shock, respectively (Fig. 1H). 
Circadian oscillations of mitochondrial function might be explained by a variety of 
mechanisms (Manella and Asher, 2016). It is formally possible that circadian control of 
expression of a key rate-limiting mitochondrial enzyme would be sufficient (Neufeld-Cohen et 
al., 2016). We observed that mitochondrial subunits of complexes I, IV, and V were expressed in 
a circadian fashion in human fibroblasts (Fig. S4A). However, it is unlikely that these variations 
would create circadian oscillations at each step of the respiratory chain. A second more 
persuasive idea is that circadian control of NAD
+
/NADH levels feeds back to control 
mitochondrial output (Asher and Schibler, 2011, Nakahata et al., 2009, Peek et al., 2013). 
Recently, it has been shown that changed in NAD
+
/NADH levels can affect activity of the 
mitochondrial deacetylase SIRT3, thereby affecting global mitochondrial protein acetylation 
(Peek et al., 2013). A third idea relates to mitochondrial morphology: for example, in the case of 
the cell cycle, direct regulation of mitochondrial morphology itself regulates all aspects of 
oxidative respiration (Mishra and Chan, 2014, Westermann, 2010). 
Mitochondria are highly mobile, dynamic organelles that continuously fuse and divide, 
thereby up- or downregulating respiration in response to cellular energy requirements (Wai and 
Langer, 2016). To investigate whether the circadian clock intervenes globally in mitochondrial 
dynamics, we assessed mitochondrial morphology in synchronized cultured fibroblasts by 
confocal microscopy (Fig. 2A, B). Matching the rhythmicity in ATP content and OxPhos 
activity (Fig. 1), we observed that mitochondrial network morphology displayed a circadian 
rhythmicity with three distinct states: tubular at 16 hours, intermediate at 20-24 hours, and 
fragmented at 28 hours post-shock (Fig. 2E, Fig. S2I-P). Similar results were obtained in 
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another circadian-rhythmic human cell line, glioma A172 (Fig. S3A-H, J) as well as in 
histological sections of hippocampus (Fig. 2C, F) and liver (Fig. S3 I, K) from wild-type mice, 
which both displayed a tubular morphology at CT0 (onset of subjective day or rest period) and a 
fragmented state CT12 (onset of subjective night or activity period). A fragmented mitochondrial 
network was detected at both time points in the hippocampus of mPer1/Per2 double mutant mice 
(Fig. 2C, D), as might be expected from their low and constant ATP levels. 
Clock control of DRP1 activity modulates circadian mitochondrial metabolism. 
A well-defined set of proteins regulates mitochondrial fission and fusion, including 
mitofusins and dynamin-related proteins. Whereas a recent study suggested circadian oscillation 
of these genes at a transcriptional level in liver (Jacobi et al., 2015), their expression levels did 
not exhibit circadian oscillations in cultured cells (Fig. S4B). However, we found circadian 
oscillations in the transcription of other mitochondrial genes encoding complex I, IV, and V 
subunits (Fig. S4A). This disparity of results across experimental systems implied that the 24-
hour oscillations in mitochondrial network architecture could be controlled by another 
mechanism. At the proteome level, it has been shown that the abundance of many key 
mitochondrial enzymes vary with time of day in clock-dependent fashion, including those whose 
transcription did not (Neufeld-Cohen et al., 2016), suggesting a possible post-transcriptional 
mechanism. 
In the context of the cell cycle, oscillations in mitochondrial dynamics are regulated via 
phosphorylation and activation/inactivation of DRP1 by kinases and phosphatases (reviewed by 
(Otera et al., 2013). The elongation of mitochondria is the direct consequence of the PKA-
mediated DRP1 phosphorylation at serine residue 637 (Ser637), which inhibits intra-molecular 
DRP1 interactions between its GTPase and GED domains, thereby impinging on DRP1 GTPase 
activity and function (Cereghetti et al., 2008, Cribbs and Strack, 2007, Chang and Blackstone, 
2007). This mechanism has been shown previously to be of importance during starvation to 
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protect starving cells from autophagy (Gomes et al., 2011). In opposition to PKA-mediated 
DRP1 phosphorylation at the key Ser637, the activation of calcineurin, which is regulated by the 
circadian clock (Huang et al., 2012), dephosphorylates DRP1 at Ser637 and consequently leads 
to organelle fragmentation by boosting DRP1 translocation to mitochondria (Cereghetti et al., 
2008, Wang et al., 2011). 
Thus, we next considered a potential contribution of the biological clock in the post-
translational modification of DRP1 by phosphorylation at Ser637 (Fig. 3). While total DRP1 
protein did not display circadian oscillation both in cell (Fig. 3A) and brain lysates of wild-type 
mice maintained in constant darkness (Fig. 3B), Ser637 phosphorylated DRP1 levels exhibited 
24-hour rhythms coinciding directly with a fused mitochondrial network with peaks occurring at 
20 hours post-shock and at CT12 (onset of the subjective night), respectively. By contrast, when 
brain lysates from mPer1/mPer2 double mutant mice were investigated, Ser637 phosphorylated 
DRP1 levels remained unchanged between CT0 and CT12 (Fig. 3C).  
We next investigated possible sources for regulation of DRP1 phosphorylation. We therefore 
evaluated the impact of pharmacological inhibition of calcineurin on DRP1 in synchronized 
human primary skin fibroblasts (Fig. 3D). We observed a significantly increased Ser637-
phosphorylation of DRP1 at all time points in the presence of calcineurin inhibitor FK506, 
resulting in abrogation of its circadian phosphorylation pattern.  
Multiple previous studies have suggested diverse methods of feedback from the circadian 
clock to oxidative metabolism, notably via the nutrient sensors AMPK (Lamia et al., 2009), 
SIRT1 (Asher et al., 2008, Nakahata et al., 2008), and SIRT3 (Peek et al., 2013). To elucidate 
whether these control nodes also impact the circadian control of DRP1 phosphorylation, we 
inhibited circadian-connected nutrient sensors AMPK, SIRT1, and SIRT3 using compound C 
(Oosterman and Belsham, 2016), Ex527 (Gertz et al., 2013), and AGK7 (Outeiro et al., 2007), 
respectively, in synchronized human primary skin fibroblasts (Fig. 3E-G). In all three scenarios, 
11 
 
Ser637-phosphorylated DRP1 did not exhibit circadian oscillations after respective inhibitor 
treatments. Taken together, these results not only suggest that mitochondrial network remodeling 
in vitro and in vivo is controlled by the circadian clock, but they also indicate that DRP1 
phosphorylation could play a central role in nutrient sensor-modulated circadian control of 
mitochondrial function. 
Finally, to determine whether circadian modulation of DRP1-dependent mitochondrial 
dynamics is indeed responsible for circadian mitochondrial output, we first took a 
pharmacological approach, treating clock-synchronized cells with P110, a specific mitochondrial 
division inhibitor (Qi et al., 2013). Treatment with this drug completely abolished circadian ATP 
variation in human skin fibroblasts (Fig. 4A). Similar results were observed in presence of 
Mdivi-1, formerly reported as a specific inhibitor of DRP1-dependent fission (Bordt et al., 2017) 
(Fig S4C). To further confirm whether inhibition or absence of DRP1 is able to impact ATP 
oscillation, we evaluated ATP content in Drp1
-/- 
MEFs, and found that cells lacking DRP1 did 
not display ATP oscillations (Fig. 4B). To further verify the role of DRP1 in controlling 
circadian ATP levels in vivo, we examined hippocampi of adult Drp1
-/- 
mice (Oettinghaus et al., 
2016) kept in constant darkness (Fig. 4C). Consistent with our in vitro observations, ATP levels 
in Drp1
-/-
 mouse hippocampi did not display a significant change between CT4 and CT16 
compared to wild-type controls. Therefore, both in vivo and in vitro, circadian activation of 
DRP1 plays a central role in coupling circadian and mitochondrial metabolic cycles. 
Overall, these data demonstrate that mitochondrial dynamics are essential for circadian 
regulation of oxidative metabolism even in non-dividing cells: analysis of DRP1 regulation 
revealed a circadian Ser637 phosphorylation pattern, and pharmacological or genetic interference 
with DRP1 activity abolishes circadian ATP production. An important consequence of DRP1 
loss is the impairment of mitochondrial architecture and distribution. In brain, this results in 
impaired synaptic transmission (Oettinghaus et al., 2016, Shields et al., 2015, Verstreken et al., 
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2005). Furthermore, DRP1 depletion also affects embryonic and brain development including 
synapse formation, as well as the survival of post-mitotic neurons (Ishihara et al., 2009, 
Kageyama et al., 2012). Thus, it cannot be excluded that loss of circadian ATP production could 
partly also be due to other neuronal dysfunctions besides mitochondrial impairment related to 
DRP1 loss. 
Mitochondrial network retrogradely signals to the molecular core clock. 
A known key aspect of circadian oxidative respiration is its ability to feed back to the 
circadian clock mechanism itself: NAD
+
 is a cofactor of the nuclear deacetylase SIRT1, which 
directly affects circadian clock function (Asher et al., 2008, Nakahata et al., 2008); in addition, 
purine nucleotide levels modulate AMPK activity to regulate phosphorylation of CRY clock 
proteins (Lamia et al., 2009, Um et al., 2011). If the morphology-driven circadian control 
mechanism that we uncovered indeed affected circadian mitochondrial function and ATP levels, 
one would predict that it should also signal back to modulate circadian function similarly to these 
other mechanisms. To test this prediction, we lentivirally infected fibroblast cells with a 
circadian reporter construct (Bmal1 promoter-driven expression of firefly luciferase) (Brown et 
al., 2005). As reported previously in other model systems, inhibition of nutrient sensors AMPK, 
SIRT1, and SIRT3 significantly increased period length (Fig. 4D, S4E). Similarly, disruption of 
mitochondrial division (P110) or calcineurin inhibition (FK506) significantly increased period 
length (Fig. 4E, S4F). These findings are consistent with the idea that DRP1-mediated 
mitochondrial ATP oscillations may also signal in retrograde fashion to the clock. To confirm 
this hypothesis, we further analyzed gene expression of the core clock activator Bmal1 and 
repressors Per1 and Per2 in serum-shocked Drp1
-/-
 MEFs (Fig. 4F, S4D). Circadian variation in 
the gene expression of clock activator Bmal1 and repressors Per1 and Per2 was suppressed, 
confirming that disruption of circadian mitochondrial dynamics leads to an impaired core 
circadian clock. 
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Conclusion and Limitations of study 
In summary, consistent with the growing body of evidence integrating cellular 
metabolism with circadian clocks (Ribas-Latre and Eckel-Mahan, 2016), our findings establish a 
molecular link between circadian control of mitochondrial morphology and oxidative 
metabolism. It suggests that the global circadian regulation of DRP1-dependent mitochondrial 
architecture plays a key role in controlling circadian metabolism. Mitochondrial morphology has 
been demonstrated previously to regulate nearly every aspect of mitochondrial function: 
mitochondrial fusion to form more extensive tubular networks results in global upregulation of 
oxidative respiration and all other functions, while fission of mitochondria into smaller 
fragments achieves the opposite (Westermann, 2010). Such regulation at the level of morphology 
has been extensively characterized within the context of the cell cycle, where different steps of 
the cell division process have disparate energy needs (Martinez-Diez et al., 2006, Mishra and 
Chan, 2014). Here we show that similar morphological control is a crucial node in circadian 
control of metabolism. Our study focused upon circadian control of the mitochondrial fission 
protein DRP1. Mitochondrial dynamics are characterized by repeated cycles of fusion and 
fission, so it is possible that circadian control of fusion, for instance via mitofusins MFN1/2, 
could also play a physiological role. Moreover, although we demonstrate that circadian control 
of mitochondrial dynamics is essential for circadian bioenergetics in a number of rodent tissues 
and cellular models, the exact upstream mechanism of circadian DRP1 phosphorylation remains 
to be elucidated. The importance of circadian regulation of oxidative phosphorylation is 
highlighted by the multiple modes of regulation that have been established: via sirtuins and 
mitochondrial protein acetylation (Peek et al., 2013), via AMPK (Hardie et al., 2012), and here 
via DRP1 and mitochondrial dynamics. However, connections among these mechanisms remain 
to be clarified. As here we suggest that mitochondrial dynamics serve as effectors or necessary 
adjuncts of other circadian signaling to mitochondria, very recent findings in this journal suggest 
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that they also serve as effectors of diet-mediated longevity (Weir et al., 2017). In reverse, 
attenuation of mitochondrial dynamics accelerates cardiac senescence (Song et al., 2017). Thus, 
our findings could have multiple implications in the context of metabolic homeostasis, both with 
respect to human health and disease, and with respect to impairment in circadian clock and/ or 
mitochondrial function. Perturbations in the clock might even be a key initiating factor for 
diseases linked to compromised mitochondrial function, including neurodegenerative disorders 
such as Alzheimer’s disease.  
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Main figure titles and legends 
Figure 1: OxPhos-dependent ATP variations are driven by the circadian clock. 
(A) Percentage of non-circadian and circadian metabolites based on JTK_CYCLE analysis (n=2 
per time point). Metabolites were considered circadian at a p-value cutoff of 0.05.  
(B, C) Compound class (B) and time-of-day distribution of peak phases (C) of rhythmic 
metabolites. 
(D) Relative total ATP level measured in serum-shocked Per1/2
−/−
 MEFs compared to WT 
MEFs (n=6 per time point, JTK_Cycle, PWT=0.000179, PKO=0.39). Right panel displays relative 
total ATP level measured in serum-shocked Per1/2
−/−
 MEFs compared to WT MEFs at 16 hours 
post-shock (peak of ATP content) and at 28 hours (trough of ATP content). 
(E) Relative total ATP levels from serum-shocked human skin fibroblasts treated with 2 - deoxy-
D-glucose (2DG, 4.5 g/L) or oligomycin (OLIGO, 2 μM) compared to non-treated cells (CTRL) 
measured at the indicated time points (n=6 per time point, JTK_Cycle, PCTRL=1.78*10
-15
, 
P2DG=9.78*10
-06
, POligo=0.461). Right panel displays relative total ATP level at 16 hours post-
shock (peak of ATP content) and at 28 hours (trough of ATP content) in control and treated 
conditions. 
Data are represented as average ± SEM. **P<0.01, ***P<0.001 for Student’s two-tailed t test 
comparing single time points between WT and mutant (D) or CTRL and treated cells (E). 
(F) Oxygen Consumption Rate (OCR) was evaluated in serum-shocked fibroblasts treated 
sequentially with oligomycin (Oligo, 2 μM), a mitochondrial ATP synthesis inhibitor; FCCP 
[carbonyl cyanide p (trifluoromethoxy) phenylhydrazone] (0.7 μM), an uncoupling agent 
allowing measurement of maximal flux; rotenone (ROT, 2 μM), a complex I inhibitor; and 
antimycin A (AA, 4 μM), a cytochrome C reductase inhibitor that blocks OxPhos, at 16 and 28 
hours post-shock, respectively. 
(G) Bioenergetic profile of synchronized fibroblasts at 16 and 28 hours post-shock, respectively. 
Basal respiration, ATP turnover and maximal respiration are determined after normalization to 
OCR allocated to non-mitochondrial respiration measured after antimycin A/ rotenone injection. 
(H) Cellular bioenergetic profile (OCR versus ECAR) evaluated at 16 and 28 hours post-shock, 
respectively, in human skin fibroblasts. Black arrow corresponds to the metabolic switch from a 
metabolically active (16 hours) to a resting state (28 hours). 
Data are represented as average ± SEM (n= 11 replicates per time point, three independent 
experiments) (F-H). **P<0.01, ***P<0.001 for Student’s two-tailed t test comparing time 
points. 
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See also Figures S1, S2 and Table S1. 
 
Figure 2: Dynamic mitochondrial architecture is controlled by the circadian clock. 
(A, B) Mitochondrial network morphology assessed in serum-shocked human skin fibroblasts at 
16 (A) and 28 (B) hours, corresponding to a tubular network and a fragmented network, 
respectively. For each representative image (A) (ii) and (B) (ii), a zoom-in image is shown 
(400%). (A) (i) and (B) (i): scale bar = 100 μm. (A) (ii) and (B) (ii): scale bar = 25 μm. 
(C, D) Mitochondrial network morphology assessed in hippocampal CA1 region from non-fasted 
wild-type mice kept (C) in darkness condition at CT0 (i) and CT12 (ii) and from mPer1/mPer2 
double mutant mice (D) in darkness condition at CT0 (i) and CT12 (ii). 
(E) Quantification of mitochondrial interconnectivity in clock-synchronized fibroblasts during 
40 hours. On average 3000-10,000 mitochondrial organelles were analyzed per time point (n = 
25-30 images per time point, JTK_Cycle, P=0.000719); images for additional time points in Fig 
S2. 
(F) Quantification of mitochondrial interconnectivity from non-fasted wild-type mice kept ad 
from mPer1/mPer2 double mutant mice in darkness condition at CT0 and CT12. On average 
3000-10,000 mitochondrial organelles were analyzed per time point (n=6 sections per condition). 
Data are represented as average ± SEM (E-F). ***P<0.001 for Student’s two-tailed t test 
comparing time points (e.g. 16h versus 28h) (E) or comparing single time points between WT 
and mutant (F). 
See also Figures S2 and S3. 
 
Figure 3: DRP1 phosphorylation is under clock control. 
(A) Left panel, representative phosphorylation of DRP1 on serine 637 (P-DRP1) and total DRP1 
evaluated at the indicated time points in serum-shocked human skin fibroblasts. Right panel, 
quantification of relative DRP1 phosphorylation normalized to calibration sample (n=6 per time 
point, JTK_Cycle, PP-DRP1=0.000628, PDRP1=0.815). 
(B) Left panel, representative phosphorylation of DRP1 on serine 637 (P-DRP1) and total DRP1 
evaluated at the indicated time points in brain homogenate of non-fasted wild-type mice kept in 
constant darkness (represented by the black bar). Right panel, quantification of relative DRP1 
phosphorylation normalized to calibration sample measured in brain homogenate (n=4 per time 
point, JTK_Cycle, PP-DRP1=0.000265, PDRP1=0.549). 
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(C) Representative phosphorylation of DRP1 on serine 637 (P-DRP1) and total DRP1 levels 
evaluated at the indicated time points in brain homogenate of non-fasted mPer1/mPer2 double 
mutant mice kept in constant darkness. 
(D-G) Representative phosphorylation of DRP1 on serine 637 (P-DRP1) and total DRP1 
evaluated at the indicated time points in serum-shocked human skin fibroblasts in presence of 
inhibitors of calcineurin (FK506, 1 μM) (D), AMPK (compound C, 1 μM) (E), sirtuin 1 (Ex527. 
1 μM) (F) or sirtuin 3 (AGK7, 1 μM) (G). 
 
Figure 4: Mitochondrial metabolism is dependent upon DRP1-related clock regulation and 
feeds back to the molecular core clock. 
(A) Left panel, relative total ATP levels from serum-shocked human skin fibroblasts treated with 
P110 (1 μM) compared to non-treated cells (CTRL) measured at the indicated time points (n=6 
per time point, JTK_Cycle, PCTRL=5.36*10
-20
, PP110=0.7592). Right panel, relative total ATP 
level at 16 hours post-shock (peak of ATP content) and at 28 hours (trough of ATP content) in 
control and treated conditions. 
(B) Left panel, relative total ATP levels from Drp1
 -/-
 MEFs compared to Drp1
lox/lox 
MEFs 
measured at the indicated time points (n=6 per time point, JTK_Cycle, PDrp1
lox/lox 
= 6.83*10
-12
, 
PDrp1
-/-
 = 0.2608). Right panel, relative total ATP level at 16 hours post-shock (peak of ATP 
content) and at 28 hours (trough of ATP content) in Drp1
lox/lox 
MEFs and Drp1 
-/-
 MEFs  
(C) Total ATP levels from hippocampus of non-fasted Drp1
 -/-
 mice compared to Drp1
lox/lox 
mice 
kept in constant darkness measured at CT4 (peak of ATP content) and at CT16 (trough of ATP 
content) (n=4 per time point). 
Data are represented as average ± SEM (A-C). ***P<0.001 for Student’s two-tailed t test 
comparing single time points between CTRL and treated cells (A) or WT and mutant (B, C). 
(D) Circadian period length determined in dexamethasone - synchronized human skin fibroblasts 
transfected with Bmal1::luciferase reporter in presence of an AMPK inhibitor (compound C, 1 
μM), a SIRT1 inhibitor (Ex527, 1 μM) and a SIRT3 inhibitor (AGK7, 1 μM) (C) compared to 
control (CTRL). 
(E) Circadian period length determined in dexamethasone - synchronized human skin fibroblasts 
transfected with Bmal1::luciferase reporter in presence of complex I inhibitor Mdivi-1 (50 μM) 
or DRP1 inhibitor P110 (1 μM), and calcineurin inhibitor (FK506, 1 μM) compared to control 
(CTRL). 
(F) Relative mRNA expression of Bmal1, Per1 and Per2 evaluated from in Drp1
 -/-
 MEFs 
compared to Drp1
lox/lox 
MEFs at 12 hours and 24 hours (n=6 per time point). 
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Bars represent the mean of three independent measurements ± SEM (D- F). ***P < 0.001 for 
Student’s two-tailed t-test comparing CTRL and treated cells (D, E) or comparing single time 
points between WT and mutant (F). 
See also Figure S4. 
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STAR Methods 
Contact for reagent and resource sharing 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Anne Eckert (anne.eckert@upkbs.ch). 
Experimental model and subject details 
Mice 
Drp1
flx/flx CreERT2 
mice were obtained by crossing Drp1
flx/flx 
mice with mice expressing an 
inducible Cre recombinase transgene under the control of the CamKIIα promoter (Cre
+
), which 
is active in the hippocampus and the cortex of adult mice (from the European Mouse Mutant 
Archive EMMA strain 02125) (Ishihara et al., 2009). At 8 weeks of age mice were injected 
intraperitoneally with 1 mg tamoxifen twice daily for five consecutive days to induce 
recombination of the Drp1 locus (Oettinghaus et al., 2016). mPer1/mPer2 double mutant mice 
were generated as described previously (Zheng et al., 2001). 
Male C57BL/6, Drp1
flx/flx CreERT2
 and mPer1/mPer2 double-mutant mice (10-12 weeks old) were 
housed at 24°C for one week on a 12:12 light-dark cycle prior to placement in constant darkness 
5 days before the beginning of the experiment with free access to ordinary food (normal chow) 
and water. Circadian time 0 (CT0) is the start of subjective daytime and CT12 is the start of 
subjective night-time, under constant dark conditions, over 24 hours. Experiments were 
performed in compliance with protocols approved by the local Basel Committee for Animal Care 
and Animal Use. 
Cell culture 
Human osteosarcoma U2OS cells (derived from a 15-years-old female donor) and human skin 
fibroblasts (derived from a 31-years-old male donor) infected with lentiviral circadian reporter 
mice Bmal1::luciferase were cultured at 37 C in a humidified incubator chamber under an 
atmosphere of 7.5% CO2 in complete Dulbecco’s modified Eagle’s medium (DMEMc, including 
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1% penicillin/streptomycin, 1% glutamax) supplemented with 20% fetal bovine serum (FBS) as 
described previously (Brown et al., 2005). 
Human glioma A172 cells were transfected with plasmid DNA of a mitochondrial targeted GFP 
(pEGFP-N1-mt-ro2GFP) (Hanson et al., 2004) using the Lipofectamine 2000 reagent. After 
transfection, cells were selected in DMEMc supplemented with 10% FBS and 300 μg/ml of the 
antibiotic Geneticin for two months at 37 C in a humidified incubator chamber under an 
atmosphere of 7.5% CO2. Glioma cells were also infected with lentiviral circadian reporter mice 
Bmal1::luciferase and the circadian period length was then determined to ensure that cells have 
normal circadian rhythms (protocol details in the Circadian period length determination 
section; data not shown: mean period length of 3 independents experiments 25.44 +/- SEM 
0.4865 hours). 
Drp1
lox/lox
 MEFs were prepared from E13.5 Drp1
lox/lox
 embryos and cultured as previously 
described (Ishihara et al., 2009). Drp1
-/-
 MEFs were subsequently generated by expression of Cre 
recombinase. The MEFs were maintained in DMEMc supplemented with 10% FBS and 1x non-
essential amino acids cultured at 37 C in a humidified incubator chamber under an atmosphere of 
7.5% CO2. 
MEFs lacking mPer1 and mPer2 isolated from double knockout mice were generated from E12 
embryos as previously described (Nagoshi et al., 2004, Zheng et al., 2001) and cultured in 
DMEMc supplemented with 10% FBS cultured at 37 C in a humidified incubator chamber under 
an atmosphere of 7.5% CO2. 
Method details 
Brain homogenate preparation 
Brains were dissected on ice and washed in ice-cold buffer (210 mM mannitol, 70 mM sucrose, 
10 mM Hepes, 1 mM EDTA, 0.45% BSA, 0.5 mM DTT, and Complete Protease Inhibitor 
mixture tablets). After removing the cerebellum, tissue samples were homogenized in 2 ml of 
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buffer with a glass homogenizer (10–15 strokes, 400 rpm). After protein concentration 
determination, all brain homogenate samples were normalized on 5 mg/ml of protein before ATP 
content measurement and on 1 mg/ml for NAD
+
/NADH content determination. 
Synchronization of circadian rhythms 
For small-molecule and period length determination, cells were synchronized by addition of 100 
nM dexamethasone in DMEMc + 20% FBS for 15 mins at 37 °C (Brown et al., 2005). For 
measurements of nucleotides levels, cell proliferation, reactive oxygen species, oxygen 
consumption rate and mitochondrial morphology, cells were synchronized by serum shock 
treatment (50% horse serum supplemented DMEMc) (Balsalobre et al., 1998). 
Small-Molecule determination. 
After dexamethasone- synchronization of circadian rhythms in U2OS cells, metabolites were 
measured from duplicate plates by Metabolon (Morrisville, NC), and data was processed as 
described previously (Dallmann et al., 2012, Lawton et al., 2008). Briefly, raw peak values of 
each biochemical were re-scaled to have median equal to 1. Because the absolute levels and thus 
the lower limit of detection were unknown, missing values were replaced by the minimum values 
observed for any given metabolite. This procedure prevented overestimation of circadian 
amplitude in less abundant substances, whose true minimum values are unknown. 
Nucleotide measurements 
Total ATP content from synchronized human skin fibroblasts, Drp1
lox/lox
 and Drp1
-/-
 MEFs, 
Per1/2
+/+
 and Per1/2
-/-
 MEFs and mice brain homogenates was determined using 
bioluminescence assay according to the instruction of the manufacturer. Briefly, the enzyme 
luciferase, which catalyzes the formation of light from ATP and luciferin was used. The emitted 
light is linearly related to the ATP concentration and is measured using a luminometer 
(VictorX5, Perkin Elmer). To define the origin of ATP oscillations, DMEMc without phenol red 
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+ 2% FBS supplemented with 2-Deoxy-D-glucose (4.5 g/l), a glycolysis inhibitor, and pyruvate 
(4 mM) or oligomycin (2 μM), an ATP synthase inhibitor, was added on synchronized human 
skin fibroblasts. To test the possibility that rhythmic ATP is a byproduct of rhythmic cell 
division, pharmacological disruption of the cell cycle was accomplished with the inhibitor AraC, 
an anticancer drug that prevents cell division (100 μm). AraC was added to human skin 
fibroblasts cultures 3 hours after the seeding, directly after the medium exchange following the 
synchronization and then every 24 hours to assure continued block of cell division. To verify if 
AraC treatment had an impact on cell cycle and blocked cell proliferation, the BrdU Cell 
Proliferation Assay was used following the instructions of the manufacturer. To investigate the 
role of clock- regulated DRP1 in mitochondrial bioenergetics, mitochondrial fission was 
abolished by selective inhibition of DRP1 using the inhibitor P110 (1 μM) or inhibition of 
complex I using the inhibitor Mdivi-1 (50 μM). 
For measurement of NAD
+
 and NADH from synchronized fibroblasts and mice brain 
homogenates, NAD
+
 and NADH were separately extracted using an acid-base extraction (HCL 
0.1 mol/l – NAOH 0.1 mol/l). The determination of both NAD
+
 and NADH was performed using 
an enzyme cycling assay based on passing the electron from ethanol trough reduced pyridine 
nucleotides to MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) in a PES- 
(phenazine ethosulfate) coupled reaction resulting in a purple formazan product that can be 
quantitatively measured at a wavelength of 595 nm (VictorX5, Perkin Elmer). 
Experiments were performed starting from 12 hours post-synchronization time point and 
measured at 4 hours intervals for 6 time points. 
ROS level 
The formation of cytosolic (cROS), mitochondrial (mROS) reactive oxygen species and 
superoxide anions in synchronized fibroblasts were measured using, the fluorescent probe 2',7'-
dichlorofuorescin diacetate (DCF) (10 μM, 15 min), the non-fluorescent dihydrorhodamine-123 
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(DHR) (10 μM, 15 min) and the Red Mitochondrial Superoxide Indicator (MitoSOX, 5 μM, 30 
min), respectively. 
Synchronized fibroblasts were loaded for 15 min with 10 μM DCF or 15 min with 10 μM DHR 
at 37 °C. After washing twice with HBSS, the formation of the reduced fluorescent product 
dichlorofluorescein was detected using the VictorX5 multilabel reader (PerkinElmer Life 
Sciences) at 485 nm (excitation)/535 nm (emission). DHR, which is oxidized to cationic 
rhodamine 123 which localizes in the mitochondria and exhibits green fluorescence, was 
detected using the VictorX5 multilabel reader at 490 nm (excitation)/590 nm (emission). The 
levels of superoxide anion radical were also assessed using the Red Mitochondrial Superoxide 
Indicator (MitoSOX, 5 μM, 30 min). MitoSOX, which is specifically oxidized by mitochondrial 
superoxide, exhibits a red fluorescence detected at 535 nm (excitation)/595 nm (emission). The 
intensity of fluorescence was proportional to mROS levels or superoxide anion radicals in 
mitochondria. Experiments were performed starting from 12 hours post-synchronization time 
point and measured at 4 hours intervals. 
Oxygen Consumption Rate (OCR) measurements 
OCR was measured in synchronized fibroblasts as recommended as previously described 
(Invernizzi et al., 2012). Briefly, human skin fibroblasts were seeded at the density of 3x10
4
 
cells/100 μl per well on Seahorse Biosciences 24-well culture plates one day prior to the 
beginning of assay. After serum shock synchronization, medium was exchanged to 500 μl of 
assay medium (glucose-free RPMI-1640 medium containing 2% FBS, 2 mM sodium pyruvate, 
pH ~ 7.4). Prior to measurements the microplates were equilibrated in a CO2 free incubator at 37 
°C for 60 minutes. The drug injections ports of the XF Assay Cartridge were loaded with the 
assay reagents at 10X in assay medium. 55 μl of oligomycin (10 μM), 62 μl of FCCP (7 μM), 
68μl of a mix of antimycin A (40 μM) and rotenone (20 μM) were added to ports A, B and C 
respectively. Experiments were performed at 16 hours post-shock and 28 hours post-shock. 
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Mitochondrial morphology 
Human skin fibroblast and mitochondrial targeted GFP transfected human glioma A172 cells 
were cultured on glass coverslips. Mitochondrial staining was performed on serum-shocked 
fibroblasts with the mitochondrial membrane potential-sensitive dye Mitotracker® Red CMX 
ROS (75nM, 15 minutes, 579/599, Life technologies). After PFA fixation, the coverslips were 
mounting using ProLong® Gold antifade reagent. 
For immunohistochemistry on brain and liver (hippocampus (CA1 region) and liver sections 
from C57BL/6 mice and from mPer1/mPer2 double-mutant mice at CT0, onset of subjective day 
or rest period, and CT12, onset of subjective night or activity period), antibody against the outer 
mitochondrial membrane porin, Voltage-Dependent Anionic Channel (VDAC, 1:75) was used 
for determining mitochondrial morphology. A FITC-labeled anti-rabbit IgG (1:160, 490/525) 
was used as secondary antibody. TO-PRO-3iode (1uM, 642/661) was used as nuclei staining 
according to the manufacturer’s recommendation. 
The acquisition of XY-confocal images with maximum intensity projection was performed using 
an inverted microscope (Leica Microsystems TCS SPE DMI4000) attached to an external light 
source for enhanced fluorescence imaging (Leica EL6000) with a ×63 oil immersion objective 
(numerical aperture 1.4; Leica). Given the flat morphology of the fibroblasts (size <3 μm in the 
axial direction), pinhole settings were chosen in such a way that axially each cell was entirely 
present within the confocal volume. For morphological analysis, the samples were blindly 
analyzed. The form factor as measurement of mitochondrial interconnectivity was calculated for 
each mitochondrial object using NIH ImageJ software (Koopman et al., 2005) . The degree of 
mitochondrial interconnectivity (perimeter
2
/4*Pi*Area) is a measure of both length and degree 
of branching. A degree of interconnectivity of 1 corresponds to a circular, unbranched 
mitochondrion whereas a higher degree of interconnectivity indicates a longer, more branched 
mitochondrion. 
32 
 
Protein gel electrophoresis and immunoblotting 
Lysates from serum-shocked fibroblast cultures and brain homogenate were prepared and protein 
expression levels were measured by standard western blot procedure. A calibration sample 
corresponding to an assembling of all the time points was also measure for normalization. We 
used primary antibodies to DRP1 (1:500, Cell Signaling), ser637-phosphorylated DRP1 (1:500, 
Cell Signaling) and VDAC (1:500, Cell Signaling) and horseradish peroxidase-coupled IgG as 
secondary antibody (1:160, Sigma). Signals were detected by enhanced chemiluminescence 
using SuperSignal™ West Dura Chemiluminescent Substrate and images were acquired using 
Gene Gnome from Syngene Bio-Imaging (CDD camera). The optical density of each band was 
quantified and normalized to the intensity of the calibration sample band using NIH ImageJ.  
Circadian period length determination 
Human skin fibroblasts and human glioma A172 cells transfected with the lentiviral circadian 
reporter mice Bmal1::luciferase (Brown et al., 2005, Gaspar and Brown, 2015) were plated in 
single culture dishes (35x10mm) at a cell density sufficient to reach 70-80% of confluency on 
the start day of recording of period length. After synchronization with dexamethasone (100 nM, 
15 mins at 37°C), cells were cultured in DMEM (CM) supplemented with 10% heat-inactivated 
FBS, 10 mM HEPES and 0.1 mM luciferin. To determine the influence of ATP on circadian 
period length, CM was supplemented with glycolysis inhibitor (2-Deoxy-glucose, 4.5 g/L) and 
pyruvate (4 mM), or the cell cycle inhibitor AraC (100 μM). To further confirm the influence of 
ATP on molecular circadian clock, CM was supplemented with nutrient sensors inhibitors: 
compound C (1 μM), an AMPK inhibitor; Ex527 (1 μM), a selective inhibitor of SIRT1; AGK7 
(1 μM), a selective inhibitor of SIRT3. To determine the role of Drp1-regulated mitochondrial 
bioenergetics, CM was supplemented with the inhibitor P110 (1 μM), a selective inhibitor of 
DRP1 or a mitochondrial division inhibitor or FK506 (1 μM), a calcineurin inhibitor. For at least 
5 days, the amount of produced light that is proportional to Bmal1 gene expression was 
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measured using a Lumicycle instrument (Actimetrics). Data were analysed with Lumicycle 
Analysis software (Lumicycle
TM
, version 2.31, Actimetrics Software) and the period of 
oscillation was calculated by least-mean-squares fitting of dampened sine wave functions to the 
actual data as described previously (Pagani et al., 2011). 
Quantitative real-time PCR 
Total RNA was extracted from lysates of synchronized fibroblasts using RNeasy Mini KIT 
(Qiagen). cDNA was generated using Ready-to-Go You-Prime First-Strand Beads (GE 
Healthcare). For data analysis, human CDK4 was used as an endogenous control. Data are 
expressed as relative expression for each individual gene normalized to their corresponding 
controls. The primers used were purchased from Applied Biosystems and Microsynth (Probe ID: 
see Table S2). Data are expressed as relative expression for each individual gene normalized to 
their corresponding controls. 
Quantification and statistical analysis 
Data were presented as mean ± S.E.M. Graph Pad Prism 5.02 was used for statistical analysis 
and data presentation. The curves were generated by using a standard curve fit function in the 
GraphPad Prism software. For statistical comparisons, a Student’s two-tailed t-test was used to 
compare single time points. Rhythmicity of metabolites and genes expression was assessed using 
an algorithm previously described for rhythmic transcripts. 
The JTK-cycle algorithm was used as implemented in R by Kronauer as previously described 
(Dallmann et al., 2012). In brief, this algorithm characterizes samples as rhythmic or 
nonrhythmic using a nonparametric method based on a combination of the Jonckheere–Terpstra 
test for monotonic ordering and Kendall’s τ test for association of measured quantities. 
Metabolites profiles were first crosschecked by visual inspection. Subsequently, the statistical 
significance of the circadian rhythmicity of each compound was evaluated with an independent 
permutation test to identify the false discovery rate for each metabolite. A window of 24 h was 
34 
 
used for the determination of circadian periodicity and a P value of <0.05 was considered as 
statistically significant. 
Statistical parameters can be found in figure legends. 
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Supplemental table 
Table S1, related to Figure 1: Complete list of all identified metabolites in serum-shocked 
U2OS. 
All values are normalized (mean±SEM). Rhythmic compounds are indicated in red color. Abbr.: 
RI: retention index, HMDB: identification numbers of biochemicals in Human Metabolome 
Database, PT-p: p-values computed with the permutation test as described in Methods, Per: 
Period, LAG: peak phases, Amp: amplitude of oscillation, defined as the maximum divided by 
the minimum level of a particular biochemical in the first 24hrs of the experiment. Phase: Phase 
of the peak for rhythmic biochemicals. 
 
Table S2: Primer sequences, related to STAR Methods section: “Quantitative real-time 
PCR”. 
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Circadian control of DRP1 activity regulates mitochondrial dynamics and bioenergetics. 
Karen Schmitt, Amandine Grimm, Robert Dallmann, Bjoern Oettinghaus, Lisa Michelle Restelli, 
Melissa Witzig, Naotada Ishihara, Katsuyoshi Mihara, Jürgen A Ripperger, Urs Albrecht, 
Stephan Frank, Steven A. Brown, Anne Eckert 
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Supplementary figure titles and legends 
Figure S1, related to Figure 1 
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(A) Heat plots for all identified metabolites in synchronized human U2OS cells. 
(B-E) Accumulation profiles of oscillating metabolites involved in branched-chain amino acid 
metabolism (B), GSH/GSSG metabolism (C), glycolysis (D), and TCA cycle (E), presented as 
mean ± SEM. Raw peak values for all metabolites were normalized to have a median of 1. 
(F) Relative total ATP levels from serum-shocked human skin fibroblasts measured at the 
indicated time points (JTK_Cycle, P=1.78*10
-15
). Right panel displays relative total ATP level at 
16 hours post-shock (peak of ATP content) and at 28 hours (trough of ATP content). 
(G) Cytosolic (cROS) and mitochondrial (mROS) reactive oxygen species levels were evaluated 
in serum-shocked human skin fibroblasts (JTK_Cycle, PmROS=5.40*10-21, PcROS=0.489). Right 
panel displays cROS and mROS levels at 16 hours post-shock (peak) and at 28 hours (trough)  
(H) Total NAD
+
 content assessed from brain of non-fasted wild-type mice kept in constant 
darkness every 4 hours for 24 hours (JTK_Cycle, P=1.23*10
-6
). Right panel displays relative 
total NAD
+
 level at CT4 (peak) and at CT16 (trough)). 
(I) Total NADH content from brain of non-fasted wild-type mice kept in constant darkness, 
assessed every 4 hours for 24 hours (JTK_Cycle, P=0.000168). Right panel displays relative 
total NAD
+
 level at CT4 (peak) and at CT16 (trough)  
All data are represented as mean ± SEM of at least three independent samples (n = 4 or 6 per 
time point) (F-I). **P<0.01, ***P < 0.001 for Student’s two-tailed t-test comparing time points 
(e.g. 16h versus 28h).  
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Figure S2, related to Figure 1 & 2
5 
 
(A) Left panel, relative total ATP contents from serum-shocked human skin fibroblasts treated 
with cytosine β-D-arabinofuranoside (AraC, 100 μM) compared to non-treated cells (CTRL) 
measured at the indicated time points in cells (n=6 per time point, JTK_Cycle, PCTRL=4.69*10
-12
, 
PAraC=3.0*10
-10
). Right panel displays relative total ATP level at 16 hours post-shock (peak of 
ATP content) and at 28 hours (trough of ATP content) in control and treated conditions).  
(B) Percentage of BrdU- positive cells in absence and presence of AraC at 24 hours post-shock. 
All data are represented as mean ± SEM of at least three independent samples (n = 4 or 6 per 
time point) (A, B). **P<0.01, ***P < 0.001 for Student’s two-tailed t-test comparing single time 
points between CTRL and treated cells. 
(C) Circadian period length determined in dexamethasone - synchronized human skin fibroblasts 
transfected with Bmal1::luciferase reporter in presence of 2 deoxy-glucose (4.5 g/L) and AraC 
(100 μM) compared to control (CRTL). 
(D) Left panel shows relative total ATP levels measured in brain of wild-type mice kept in 
constant darkness (WT Brain) every 4 hours for 24 hours (7 time points, n=4 for each, 
JTK_Cycle, P=0.0077). Right panel displays relative total ATP level at circadian time 4 (CT4; 
peak of ATP content) and 16 (CT16; trough of ATP content) (). 
(E) Total NAD
+
 measured in serum-shocked human skin fibroblasts at the indicated time points 
(6 time points, n=6 for each, JTK_Cycle, P=2.18*10
-8
). Right panel displays relative total NAD
+
 
level at 16 hours post-shock (peak) and at 28 hours (trough)). 
(F) Total NADH measured in serum-shocked human skin fibroblasts at the indicated time points 
(6 time points, n=6 for each, JTK_Cycle, P=6.68*10
-5
). Right panel displays relative total NAD
+
 
level at 16 hours post-shock (peak) and at 28 hours (trough)). 
All data are represented as mean ± SEM (D-F). **P<0.01, ***P < 0.001 for Student’s two-tailed 
t-test comparing single time points (16 versus 28 hours). 
(G) OCR related to the proton leak (independent to ATP production) at 16 hours post-shock and 
28 hours post-shock in human skin fibroblast. 
(H) Extracellular Acidification Rate (ECAR) corresponding to glycolytic rate at 16 hours post-
shock and 28 hours post-shock in human skin fibroblast. 
All data are represented as mean ± SEM of three independent samples (n= 11 per time point). 
(I-P) Mitochondrial network morphology assessed at 4 hours intervals for 8 time points in 
synchronized fibroblasts (I, K, L, N, O) Intermediate network; (J, P) Tubular network; (M) 
Fragmented network. For each representative image, a zoom-in image is provided (400%). Scale 
bar = 25 μm.  
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Figure S3, related to Figure 2 
 
7 
 
(A-H) Mitochondrial network morphology assessed at 4 hours intervals for 8 time points in 
synchronized A172 glioma cells transfected with a GFP plasmid containing a mitochondrial 
targeting sequence. (A, C, G) Intermediate network; (B, H) Tubular network; (D, E, F) 
Fragmented network. For each representative image, a zoom-in image is provided (400%). Scale 
bar = 25 μm.  
(I) Mitochondrial network morphology assessed in liver sections from non-fasted wild-type mice 
kept in darkness condition at CT0 (i) and CT12 (ii). Scale bar = 50 μm. 
(J) Quantification of mitochondrial interconnectivity corresponding to the conditions A to H. On 
average 10`000-20`000 mitochondrial organelles were analyzed per time point (n = 25-30 
images per time point; JTK_Cycle, P = 0.000607). 
(K) Quantification of mitochondrial interconnectivity at CT0 and CT12 (n=6 sections per 
condition,). On average 2`500-8`500 mitochondrial units were analyzed per time point.  
Data are represented as average ± SEM (J, K). ***P<0.001 for Student’s two-tailed t test 
comparing single time points.  
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Figure S4, related to figure 4 
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(A) Relative mRNA expression of complex I, IV and V subunits at 16 hours post-shock 
(corresponding to the peak in gene expression) and 28 hours post-shock (corresponding to the 
trough in gene expression) (JTK_Cycle, PNDUFA2=3.96*10
-5
, PNDUFB5=8.57*10
-6
, 
PNDUFC1=4.88*10
-15
, and PNDUFV2=7.61*10
-5
).  
(B) Profile of relative mRNA expression of nuclearly-encoded genes related to mitochondrial 
fusion (MFN1, MFN2 and OPA1) and mitochondrial fission (DRP1 and hFIS1) in serum-
shocked human skin fibroblasts (JTK_Cycle, PMFN1=0.809, PMFN2=0.426, POPA1=0.175, 
PDRP1=0.215, PhFIS1=0.827). 
(C) Left panel, relative total ATP levels from serum-shocked human skin fibroblasts treated with 
Mdivi-1 (50 μM) compared to non-treated cells (CTRL) measured at the indicated time points 
(n=6 per time point, JTK_Cycle, PCTRL=5.36*10-20, PMdivi-1=0.8581). Right panel, relative total 
ATP level at 16 hours post-shock (peak of ATP content) and at 28 hours (trough of ATP content) 
in control and treated conditions. 
All data are represented as mean ± SEM of at least three independent samples (n=6 per time 
point,) (A- C). *P<0.05, **P<0.01, ***P<0.001 for Student’s two-tailed t test comparing single 
time points (A, B) or comparing single time points between CTRL and treated cells (C). 
(D) Relative mRNA expression of Bmal1 evaluated from in Drp1 
-/-
 MEFs compared to 
Drp1
lox/lox 
MEFs at 12, 18, 24, 30 and 36 hours post-shock (n=6 per time point, JTK_Cycle, P 
Drp1
lox/lox
 =0.000951, P Drp1
-/-
 =0.864).  
(E, F) Representative bioluminescence records determined in dexamethasone - synchronized 
human skin fibroblasts transfected with Bmal1::luciferase reporter in presence of (E) an AMPK 
inhibitor (compound C, 1 μM) and (F) a DRP1 inhibitor, P110 (1 μM), compared to control 
(CTRL) (n = 3).  
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Table S2: Primer sequences, related to STAR Methods section: “Quantitative real-time 
PCR”. 
 Primer Probe ID (Applied Biosystems) 
Fusion MFN1 Hs00250475_m1 
 MFN2 Hs00208382_m1 
 OPA1 Hs00323399_m1 
Fission DRP1 Hs00247147_m1 
 FIS1 Hs00211420_m1 
OXPHOS NDUFA2 (complex I) Hs00159575_m1 
 NDUFB5 (complex I) Hs00159582_m1 
 NDUFC1 (complex I) Hs00159587_m1 
 NDUFV2 (complex I) Hs00221478_m1 
 COX4I1 (complex IV) Hs00971639_m1 
 COX6A1 (complex IV) Hs01924685_g1 
 COX7A2 (complex IV) Hs01652418_m1 
 COX7B (complex IV) Hs00371307_m1 
 ATP5G2 (ATP synthase) Hs01096582_m1 
 ATP5C1 (ATP synthase) Hs01101219_g1 
 ATP5L (ATP synthase) Hs00758883_s1 
 
Primer Sequence (Microsynth) 
BMAL1 forward, 5'-GAAGACAACGAACCAGACAATGAG-3' 
reverse, 5'-ACATGAGAATGCAGTCGTCCAA-3' 
probe, 5'-Yakima Yellow-TGTAACCTCAGCTGCCTCGTCGCA-BHQ1-3' 
PER1 forward, 5'-CGCCTAACCCCGTATGTGA-3' 
reverse, 5'-CGCGTAGTGAAAATCCTCTTGTC-3' 
probe, 5'-Yakima Yellow-CGCATCCATTCGGGTTACGAAGCTC-BHQ1-3' 
PER2 forward, 5'-GGGCAGCCTTTCGACTATTCT-3' 
reverse, 5'-GCTGGTGTCCAACGTGATGTACT-3' 
5'-Yakima Yellow-CATTCGGTTTCGCGCCCGGG-BHQ1-3' 
 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
DRP1 (D6C7) Rabbit mAb Cell Signaling 
Technology 
Cat# 8570S, 
RRID:AB_10950498 
Phospho-DRP1 (Ser637) Antibody Cell Signaling 
Technology 
Cat# 4867S, 
RRID:AB_10622027 
VDAC Antibody Cell Signaling 
Technology 
Cat# 4866, 
RRID:AB_2272627 
Bacterial and Virus Strains  
   
   
Biological Samples   
   
   
Chemicals, Peptides, and Recombinant Proteins 
Dexamethasone  Sigma-Aldrich Cat#D1756; CAS: 50-
02-2 
Cytosine β-D-arabinofuranoside hydrochloride (AraC) Sigma-Aldrich Cat#C6645; CAS: 69-
74-9 
2-deoxy-D-glucose Sigma-Aldrich Cat#D6134; CAS: 
154-17-6 
2',7'-Dichlorofuorescin diacetate Sigma-Aldrich D6883; CAS: 4091-
99-0 
Dihydrorhodamine-123 Sigma-Aldrich D1054; CAS: 
109244-58-8 
P110  
(H  -  YGR KKR RQR RRG GDL LPR GS  -  NH2  (20AA)) 
Eurogentec 
(Qi et al, 2013) 
Peptide Custom 
Synthesis 
Mdivi-1 (Drp1 inhibitor) Sigma-Aldrich Cat#M0199; CAS: 
338967-87-6 
MitoSOX™ Red Mitochondrial Superoxide Indicator, for 
live-cell imaging 
ThermoFisher 
Scientific 
Cat#M36008 
Mitotracker Red CMX ROS ThermoFisher 
Scientific 
Cat#M7512; CAS: 
167095-09-2 
To-PRO-3 iode ThermoFisher 
Scientific 
Cat#T3605; CAS: 
157199-63-8 
DyNamo ColorFlash Probe qPCR Kit ThermoFisher 
Scientific 
Cat#456L 
SuperSignal West Dura Chemiluminescent Substrate ThermoFisher 
Scientific 
Cat#34075 
Lipofectamine 2000 Transfection Reagent ThermoFisher 
Scientific 
Cat#11668019 
Compound C (BML-275; AMPK inhibitor) Enzo Life Sciences Cat#BML-El369; 
CAS: 866405-64-3 
AGK7 (Sirt3 inhibitor) Enzo Life Sciences Cat#ENZ-CHM146; 
CAS: 304896-21-7 
FK506 (Calcineurin inhibitor) Enzo Life Sciences Cat#ALX-380-008; 
CAS: 104987-11-3 
Ex527 (Selisistat; Sirt1 inhibitor) Selleck Chemicals Cat#S1541; CAS: 
49843-98-3 
Critical Commercial Assays 
Vialight TM Plus Cell Proliferation and Cytotoxicity 
BioAssay Kit 
Lonza Cat#LT07-321 
Seahorse XF FluxPak  Agilent Seahorse XF 
Technology 
Cat#100850-001 
Seahorse XF Cell Mito Stress Test Kit Agilent Seahorse XF 
Technology 
Cat#103015-100 
BrdU Cell Proliferation Assay Merk Millipore Cat#QIQ58 
RNeasy Mini KIT Qiagen Cat#74104 
Ready-To-Go You-Prime First-Strand Beads GE Healthcare Life 
Sciences 
Cat#27-9264-01 
ProLong® Gold antifade reagent ThermoFisher 
Scientific 
Cat#P36930 
Deposited Data 
   
Experimental Models: Cell Lines 
Human: primary skin fibroblasts Isolated from subjects 
(Pagani et al.,2011) 
N/A 
Human: osteosarcoma U2OS cell line The Brown Laboratory RRID:CVCL_0042 
Human: glioma A172 cell line The Brown Laboratory RRID:CVCL_0131 
Mouse: Drp1lox/lox and Drp1-/- mouse embryonic 
fibroblasts 
The Ishihara and 
Mihara Laboratories 
 
Mouse: mPer1/mPer2+/+ and-/- mouse embryonic 
fibroblasts 
The Albrecht 
Laboratory 
 
Experimental Models: Organisms/Strains 
Mouse: Drp1 flx/flx and Drp1 flx/flx CreERT2 C57BL/6J The Ishihara and 
Mihara Laboratories 
Ishihara et al., 2009 
Mouse: mPer1/mPer2 +/+ and mPer1/mPer2 -/- 
C57BL/6J 
The Albrecht 
Laboratory 
Zheng et al., 2001 
Oligonucleotides 
Primers for mitochondrial fusion/fission, please see 
Table S2 
This paper N/A 
Primers for OxPhos subunits, please see Table S2 This paper N/A 
Primers for clock genes, please see Table S2 This paper N/A 
Recombinant DNA 
pABpuro-BluF (luciferase reporter for BmalI promoter) Brown et al., 2005 Addgene Plasmid, 
Cat#46824 
pEGFP-N1-mt-ro2GFP (gift from S. James Remington) Hanson et al.,2004 Addgene Plasmid, 
Cat#82408 
Software and Algorithms 
Prism Version 5.02 GraphPad https://www.graphpa
d.com/scientific-
software/prism/ 
ImageJ  NIH https://imagej.nih.go
v/ij/ 
JTK-cycle algorithm Dallmann et al. 2012 http://www.openwe
tware.org/wiki/Hug
hesLab:JTK_Cycle 
Other 
   
 
 
